Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Roivant Sciences Ltd. | Pres&Chief Investment Officer, Director | Common Shares | 18.8M | $226M | $12.01 | Dec 26, 2024 | Direct |
Roivant Sciences Ltd. | Pres&Chief Investment Officer, Director | Capped Value Appreciation Rights | 0 | $0 | $6.40 | Mar 30, 2024 | Direct |
Roivant Sciences Ltd. | Pres&Chief Investment Officer, Director | Stock Option (Right to Buy) | 15.2M | Dec 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ROIV | Roivant Sciences Ltd. | Dec 23, 2024 | 9 | -$7.23M | 4 | Dec 26, 2024 | Pres&Chief Investment Officer, Director |
ROIV | Roivant Sciences Ltd. | Dec 18, 2024 | 3 | -$3.38M | 4 | Dec 20, 2024 | Pres&Chief Investment Officer, Director |
ROIV | Roivant Sciences Ltd. | Dec 3, 2024 | 1 | -$44.6M | 4 | Dec 5, 2024 | Pres&Chief Investment Officer, Director |
ROIV | Roivant Sciences Ltd. | Jul 26, 2024 | 2 | $0 | 4 | Jul 30, 2024 | Pres&Chief Investment Officer, Director |
ROIV | Roivant Sciences Ltd. | Mar 30, 2024 | 3 | -$15.7M | 4 | Apr 2, 2024 | Pres&Chief Investment Officer, Director |
ROIV | Roivant Sciences Ltd. | Dec 27, 2023 | 3 | -$1.34M | 4 | Dec 29, 2023 | Pres&Chief Investment Officer |
ROIV | Roivant Sciences Ltd. | Sep 27, 2023 | 3 | -$666K | 4 | Sep 29, 2023 | Pres&Chief Investment Officer |
ROIV | Roivant Sciences Ltd. | Aug 27, 2023 | 2 | -$339K | 4 | Aug 29, 2023 | Pres&Chief Investment Officer |
ROIV | Roivant Sciences Ltd. | Jul 27, 2023 | 2 | -$679K | 4 | Jul 31, 2023 | Pres&Chief Investment Officer |
ROIV | Roivant Sciences Ltd. | May 27, 2023 | 2 | -$2.04M | 4 | May 31, 2023 | Pres & Chief Investment Officer |
ROIV | Roivant Sciences Ltd. | Apr 20, 2022 | 1 | $0 | 4 | Apr 22, 2022 | Pres & Chief Investment Officer |
ROIV | Roivant Sciences Ltd. | Oct 1, 2021 | 0 | $0 | 3 | Oct 1, 2021 | Pres &Chief Investment Officer |